Eli Lilly's COVID-19 antibody drug gets interim authorization in Canada squib

Virus Outbreak-Antibody Drug

Canada has granted interim authorization to Eli Lilly's antibody drug for treating COVID-19 in patients who are not hospitalized but are at risk of serious illness because of their age or other conditions, the drug-maker said on Friday.

Continue reading on CBC...